ADA-话题@MedSci

#ADA#

386篇内容 | 2830人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1264603, encodeId=d6921264603ec, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=2016ADA/AAPD循证临床实践指南——窝沟封闭剂的应用发布, objectType=article, longId=74320, objectId=ee6de4320c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee6de4320c6, replyNumber=0, likeNumber=20, createdTime=2016-08-04, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee6de4320c6, moduleTitle=2016ADA/AAPD循证临床实践指南——窝沟封闭剂的应用发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee6de4320c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264602, encodeId=8d46126460244, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=赵水平解读ADA糖尿病指南：几乎所有糖尿病患者都需加用他汀, objectType=article, longId=73407, objectId=a5a6e34077d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a5a6e34077d, replyNumber=0, likeNumber=77, createdTime=2016-07-23, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a5a6e34077d, moduleTitle=赵水平解读ADA糖尿病指南：几乎所有糖尿病患者都需加用他汀, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a5a6e34077d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264601, encodeId=10a61264601d9, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=ADA 2016：利拉鲁肽新近进展精华荟萃, objectType=article, longId=71909, objectId=b533e1909cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b533e1909cf, replyNumber=0, likeNumber=65, createdTime=2016-07-02, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b533e1909cf, moduleTitle=ADA 2016：利拉鲁肽新近进展精华荟萃, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b533e1909cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264600, encodeId=b0441264600f5, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=ADA 2016：前沿！美国糖尿病年会研究精选 TOP7, objectType=article, longId=71492, objectId=b218e1492f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b218e1492f9, replyNumber=0, likeNumber=50, createdTime=2016-06-25, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b218e1492f9, moduleTitle=ADA 2016：前沿！美国糖尿病年会研究精选 TOP7, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b218e1492f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264598, encodeId=904c126459818, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=ADA 2016：默沙东生物类似物MK-1293治疗1型和2型糖尿病III期临床疗效媲美来得时（Lantus）, objectType=article, longId=71288, objectId=4a51e128881, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4a51e128881, replyNumber=0, likeNumber=77, createdTime=2016-06-22, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4a51e128881, moduleTitle=ADA 2016：默沙东生物类似物MK-1293治疗1型和2型糖尿病III期临床疗效媲美来得时（Lantus）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4a51e128881)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264599, encodeId=2063126459910, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=ADA 2016：诺和诺德速效门冬胰岛素治疗1型糖尿病和2型糖尿病降血糖疗效媲美NovoRapid（门冬胰岛素）, objectType=article, longId=71289, objectId=7a0fe1289c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a0fe1289c2, replyNumber=0, likeNumber=0, createdTime=2016-06-22, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a0fe1289c2, moduleTitle=ADA 2016：诺和诺德速效门冬胰岛素治疗1型糖尿病和2型糖尿病降血糖疗效媲美NovoRapid（门冬胰岛素）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7a0fe1289c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264597, encodeId=7632126459e6f, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=【热点汇总】ADA 2016：凝聚世界糖尿病学专家的智慧！, objectType=article, longId=70560, objectId=880be056034, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=880be056034, replyNumber=0, likeNumber=15, createdTime=2016-06-21, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=880be056034, moduleTitle=【热点汇总】ADA 2016：凝聚世界糖尿病学专家的智慧！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=880be056034)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264596, encodeId=1a771264596c5, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=ADA 2016：自动化释放胰高血糖素可降低1型糖尿病患者的低血糖风险, objectType=article, longId=71172, objectId=a60ae1172ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a60ae1172ba, replyNumber=0, likeNumber=78, createdTime=2016-06-19, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a60ae1172ba, moduleTitle=ADA 2016：自动化释放胰高血糖素可降低1型糖尿病患者的低血糖风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a60ae1172ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264595, encodeId=547c1264595e6, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=ADA 2016：吡格列酮可降低伴卒中史的前驱糖尿病患者的糖尿病风险, objectType=article, longId=71171, objectId=908ae117130, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=908ae117130, replyNumber=0, likeNumber=59, createdTime=2016-06-19, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=908ae117130, moduleTitle=ADA 2016：吡格列酮可降低伴卒中史的前驱糖尿病患者的糖尿病风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=908ae117130)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264594, encodeId=acc8126459422, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=ADA 2016：糖尿病高危患者可通过生活方式干预延迟或预防疾病发生, objectType=article, longId=71170, objectId=a8e4e117029, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a8e4e117029, replyNumber=0, likeNumber=62, createdTime=2016-06-19, rootId=0, userName=智智灵药, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a8e4e117029, moduleTitle=ADA 2016：糖尿病高危患者可通过生活方式干预延迟或预防疾病发生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a8e4e117029)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264593, encodeId=850a12645933f, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=【2016 ADA】猪胰岛移植可能成为糖尿病治疗新方向, objectType=article, longId=71109, objectId=37fee110961, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=37fee110961, replyNumber=0, likeNumber=67, createdTime=2016-06-19, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=37fee110961, moduleTitle=【2016 ADA】猪胰岛移植可能成为糖尿病治疗新方向, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=37fee110961)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264592, encodeId=81a21264592c9, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=李光伟团队在ADA报告大庆研究23年随访新发现：甘油三酯每增加一个单位，国人心血管病风险增加 8%, objectType=article, longId=71097, objectId=79c6e1097c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=79c6e1097c2, replyNumber=0, likeNumber=64, createdTime=2016-06-19, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=79c6e1097c2, moduleTitle=李光伟团队在ADA报告大庆研究23年随访新发现：甘油三酯每增加一个单位，国人心血管病风险增加 8%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=79c6e1097c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264588, encodeId=3b9b1264588b0, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=ADA 2016：礼来每周一次降糖药Trulicity（度拉鲁肽）联合甘精胰岛素显著改善2型糖尿病患者血糖控制, objectType=article, longId=71031, objectId=ed04e103173, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed04e103173, replyNumber=0, likeNumber=66, createdTime=2016-06-18, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed04e103173, moduleTitle=ADA 2016：礼来每周一次降糖药Trulicity（度拉鲁肽）联合甘精胰岛素显著改善2型糖尿病患者血糖控制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ed04e103173)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264589, encodeId=a6781264589ed, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=ADA 2016：诺和诺德降糖药Tresiba（德谷胰岛素U100）治疗1型糖尿病和2型糖尿病低血糖风险显著优于来得时（甘精胰岛素U100）, objectType=article, longId=71032, objectId=f516e10324f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f516e10324f, replyNumber=0, likeNumber=73, createdTime=2016-06-18, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f516e10324f, moduleTitle=ADA 2016：诺和诺德降糖药Tresiba（德谷胰岛素U100）治疗1型糖尿病和2型糖尿病低血糖风险显著优于来得时（甘精胰岛素U100）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f516e10324f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264590, encodeId=db7f1264590ca, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=ADA 2016：诺和诺德第二款兼具降糖及减肥的降糖药semaglutide（索马鲁肽）III期临床疗效显著, objectType=article, longId=71033, objectId=e336e1033ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e336e1033ae, replyNumber=0, likeNumber=57, createdTime=2016-06-18, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e336e1033ae, moduleTitle=ADA 2016：诺和诺德第二款兼具降糖及减肥的降糖药semaglutide（索马鲁肽）III期临床疗效显著, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e336e1033ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264591, encodeId=092f126459157, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=ADA 2016：勃林格-礼来降糖药Tradjenta（利拉利汀）显著降低伴有肾损伤风险的2型糖尿病患者血糖水平, objectType=article, longId=71034, objectId=fefbe10347d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fefbe10347d, replyNumber=0, likeNumber=86, createdTime=2016-06-18, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fefbe10347d, moduleTitle=ADA 2016：勃林格-礼来降糖药Tradjenta（利拉利汀）显著降低伴有肾损伤风险的2型糖尿病患者血糖水平, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fefbe10347d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264587, encodeId=b314126458e16, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=ADA 2016：肥胖2型糖尿病患者的管理Roux-en-Y胃旁路术或许更佳, objectType=article, longId=70940, objectId=a7b5e09408b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a7b5e09408b, replyNumber=0, likeNumber=77, createdTime=2016-06-17, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a7b5e09408b, moduleTitle=ADA 2016：肥胖2型糖尿病患者的管理Roux-en-Y胃旁路术或许更佳, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a7b5e09408b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264586, encodeId=9fa5126458666, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=ADA 2016： iGlarLixi-血糖控制不佳患者的新选择, objectType=article, longId=70939, objectId=a555e093967, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a555e093967, replyNumber=0, likeNumber=50, createdTime=2016-06-17, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a555e093967, moduleTitle=ADA 2016： iGlarLixi-血糖控制不佳患者的新选择, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a555e093967)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264585, encodeId=535c126458505, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=ADA 2016：恩格列净能减缓2型糖尿病患者的肾病进展, objectType=article, longId=70938, objectId=e1efe09382a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e1efe09382a, replyNumber=0, likeNumber=65, createdTime=2016-06-17, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e1efe09382a, moduleTitle=ADA 2016：恩格列净能减缓2型糖尿病患者的肾病进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e1efe09382a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264584, encodeId=9282126458446, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=ADA 2016：生活压力会增加遗传风险儿童的糖尿病风险, objectType=article, longId=70937, objectId=c0bde093782, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0bde093782, replyNumber=0, likeNumber=0, createdTime=2016-06-17, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0bde093782, moduleTitle=ADA 2016：生活压力会增加遗传风险儿童的糖尿病风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c0bde093782)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ADA

2020-05-29

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

2016ADA/AAPD循证临床实践指南——窝沟封闭剂的应用发布

2016-08-04

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

赵水平解读ADA糖尿病指南：几乎所有糖尿病患者都需加用他汀

2016-07-23

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

ADA 2016：利拉鲁肽新近进展精华荟萃

2016-07-02

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

ADA 2016：前沿！美国糖尿病年会研究精选 TOP7

2016-06-25

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

ADA 2016：默沙东生物类似物MK-1293治疗1型和2型糖尿病III期临床疗效媲美来得时（Lantus）

2016-06-22

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

ADA 2016：诺和诺德速效门冬胰岛素治疗1型糖尿病和2型糖尿病降血糖疗效媲美NovoRapid（门冬胰岛素）

2016-06-22

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

【热点汇总】ADA 2016：凝聚世界糖尿病学专家的智慧！

2016-06-21

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

ADA 2016：自动化释放胰高血糖素可降低1型糖尿病患者的低血糖风险

2016-06-19

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

ADA 2016：吡格列酮可降低伴卒中史的前驱糖尿病患者的糖尿病风险

2016-06-19

智智灵药 (审核中...)

前往app查看评论内容

#ADA#

ADA 2016：糖尿病高危患者可通过生活方式干预延迟或预防疾病发生

2016-06-19

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

【2016 ADA】猪胰岛移植可能成为糖尿病治疗新方向

2016-06-19

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

李光伟团队在ADA报告大庆研究23年随访新发现：甘油三酯每增加一个单位，国人心血管病风险增加 8%

2016-06-19

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

ADA 2016：礼来每周一次降糖药Trulicity（度拉鲁肽）联合甘精胰岛素显著改善2型糖尿病患者血糖控制

2016-06-18

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

ADA 2016：诺和诺德降糖药Tresiba（德谷胰岛素U100）治疗1型糖尿病和2型糖尿病低血糖风险显著优于来得时（甘精胰岛素U100）

2016-06-18

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

ADA 2016：诺和诺德第二款兼具降糖及减肥的降糖药semaglutide（索马鲁肽）III期临床疗效显著

2016-06-18

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

ADA 2016：勃林格-礼来降糖药Tradjenta（利拉利汀）显著降低伴有肾损伤风险的2型糖尿病患者血糖水平

2016-06-18

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

ADA 2016：肥胖2型糖尿病患者的管理Roux-en-Y胃旁路术或许更佳

2016-06-17

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

ADA 2016： iGlarLixi-血糖控制不佳患者的新选择

2016-06-17

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

ADA 2016：恩格列净能减缓2型糖尿病患者的肾病进展

2016-06-17

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

ADA 2016：生活压力会增加遗传风险儿童的糖尿病风险

2016-06-17

科室
- - 订阅+
  - 更多科室
工具
服务